Global Eosinophilic Esophagitis Drug Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Eosinophilic Esophagitis Drug market size is predicted to grow from US$ 148 million in 2025 to US$ 207 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
LP Information, Inc. (LPI) ' newest research report, the “Eosinophilic Esophagitis Drug Industry Forecast” looks at past sales and reviews total world Eosinophilic Esophagitis Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Eosinophilic Esophagitis Drug sales for 2025 through 2031. With Eosinophilic Esophagitis Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eosinophilic Esophagitis Drug industry.
This Insight Report provides a comprehensive analysis of the global Eosinophilic Esophagitis Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eosinophilic Esophagitis Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eosinophilic Esophagitis Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eosinophilic Esophagitis Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eosinophilic Esophagitis Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Eosinophilic Esophagitis Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Eosinophilic Esophagitis Drug market?
What factors are driving Eosinophilic Esophagitis Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eosinophilic Esophagitis Drug market opportunities vary by end market size?
How does Eosinophilic Esophagitis Drug break out by Type, by Application?
The global Eosinophilic Esophagitis Drug market size is predicted to grow from US$ 148 million in 2025 to US$ 207 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.
LP Information, Inc. (LPI) ' newest research report, the “Eosinophilic Esophagitis Drug Industry Forecast” looks at past sales and reviews total world Eosinophilic Esophagitis Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Eosinophilic Esophagitis Drug sales for 2025 through 2031. With Eosinophilic Esophagitis Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eosinophilic Esophagitis Drug industry.
This Insight Report provides a comprehensive analysis of the global Eosinophilic Esophagitis Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eosinophilic Esophagitis Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eosinophilic Esophagitis Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eosinophilic Esophagitis Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eosinophilic Esophagitis Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Eosinophilic Esophagitis Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Budesonide
- Fluticasone
- Others
- Hospitals
- Clinics
- Drugstore
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- GSK
- Bayer
- Adare Pharmaceuticals
- DBV Technologies
- Dr. Falk Pharma
- Quorum Innovations
- Takeda
- Calypso
- Celgene
- Regeneron
What is the 10-year outlook for the global Eosinophilic Esophagitis Drug market?
What factors are driving Eosinophilic Esophagitis Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eosinophilic Esophagitis Drug market opportunities vary by end market size?
How does Eosinophilic Esophagitis Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Eosinophilic Esophagitis Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Eosinophilic Esophagitis Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Eosinophilic Esophagitis Drug by Country/Region, 2020, 2024 & 2031
2.2 Eosinophilic Esophagitis Drug Segment by Type
2.2.1 Budesonide
2.2.2 Fluticasone
2.2.3 Others
2.3 Eosinophilic Esophagitis Drug Sales by Type
2.3.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Eosinophilic Esophagitis Drug Sale Price by Type (2020-2025)
2.4 Eosinophilic Esophagitis Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstore
2.5 Eosinophilic Esophagitis Drug Sales by Application
2.5.1 Global Eosinophilic Esophagitis Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Eosinophilic Esophagitis Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Eosinophilic Esophagitis Drug Breakdown Data by Company
3.1.1 Global Eosinophilic Esophagitis Drug Annual Sales by Company (2020-2025)
3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
3.2 Global Eosinophilic Esophagitis Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
3.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
3.3 Global Eosinophilic Esophagitis Drug Sale Price by Company
3.4 Key Manufacturers Eosinophilic Esophagitis Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eosinophilic Esophagitis Drug Product Location Distribution
3.4.2 Players Eosinophilic Esophagitis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EOSINOPHILIC ESOPHAGITIS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Eosinophilic Esophagitis Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Eosinophilic Esophagitis Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Eosinophilic Esophagitis Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Eosinophilic Esophagitis Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Eosinophilic Esophagitis Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Eosinophilic Esophagitis Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Eosinophilic Esophagitis Drug Sales Growth
4.4 APAC Eosinophilic Esophagitis Drug Sales Growth
4.5 Europe Eosinophilic Esophagitis Drug Sales Growth
4.6 Middle East & Africa Eosinophilic Esophagitis Drug Sales Growth
5 AMERICAS
5.1 Americas Eosinophilic Esophagitis Drug Sales by Country
5.1.1 Americas Eosinophilic Esophagitis Drug Sales by Country (2020-2025)
5.1.2 Americas Eosinophilic Esophagitis Drug Revenue by Country (2020-2025)
5.2 Americas Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
5.3 Americas Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eosinophilic Esophagitis Drug Sales by Region
6.1.1 APAC Eosinophilic Esophagitis Drug Sales by Region (2020-2025)
6.1.2 APAC Eosinophilic Esophagitis Drug Revenue by Region (2020-2025)
6.2 APAC Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
6.3 APAC Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Eosinophilic Esophagitis Drug by Country
7.1.1 Europe Eosinophilic Esophagitis Drug Sales by Country (2020-2025)
7.1.2 Europe Eosinophilic Esophagitis Drug Revenue by Country (2020-2025)
7.2 Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
7.3 Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Eosinophilic Esophagitis Drug by Country
8.1.1 Middle East & Africa Eosinophilic Esophagitis Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Eosinophilic Esophagitis Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eosinophilic Esophagitis Drug
10.3 Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
10.4 Industry Chain Structure of Eosinophilic Esophagitis Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eosinophilic Esophagitis Drug Distributors
11.3 Eosinophilic Esophagitis Drug Customer
12 WORLD FORECAST REVIEW FOR EOSINOPHILIC ESOPHAGITIS DRUG BY GEOGRAPHIC REGION
12.1 Global Eosinophilic Esophagitis Drug Market Size Forecast by Region
12.1.1 Global Eosinophilic Esophagitis Drug Forecast by Region (2026-2031)
12.1.2 Global Eosinophilic Esophagitis Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Eosinophilic Esophagitis Drug Forecast by Type (2026-2031)
12.7 Global Eosinophilic Esophagitis Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Adare Pharmaceuticals
13.4.1 Adare Pharmaceuticals Company Information
13.4.2 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Adare Pharmaceuticals Main Business Overview
13.4.5 Adare Pharmaceuticals Latest Developments
13.5 DBV Technologies
13.5.1 DBV Technologies Company Information
13.5.2 DBV Technologies Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DBV Technologies Main Business Overview
13.5.5 DBV Technologies Latest Developments
13.6 Dr. Falk Pharma
13.6.1 Dr. Falk Pharma Company Information
13.6.2 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dr. Falk Pharma Main Business Overview
13.6.5 Dr. Falk Pharma Latest Developments
13.7 Quorum Innovations
13.7.1 Quorum Innovations Company Information
13.7.2 Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Quorum Innovations Main Business Overview
13.7.5 Quorum Innovations Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 Calypso
13.9.1 Calypso Company Information
13.9.2 Calypso Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Calypso Main Business Overview
13.9.5 Calypso Latest Developments
13.10 Celgene
13.10.1 Celgene Company Information
13.10.2 Celgene Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Celgene Main Business Overview
13.10.5 Celgene Latest Developments
13.11 Regeneron
13.11.1 Regeneron Company Information
13.11.2 Regeneron Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Regeneron Main Business Overview
13.11.5 Regeneron Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Eosinophilic Esophagitis Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Eosinophilic Esophagitis Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Eosinophilic Esophagitis Drug by Country/Region, 2020, 2024 & 2031
2.2 Eosinophilic Esophagitis Drug Segment by Type
2.2.1 Budesonide
2.2.2 Fluticasone
2.2.3 Others
2.3 Eosinophilic Esophagitis Drug Sales by Type
2.3.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Eosinophilic Esophagitis Drug Sale Price by Type (2020-2025)
2.4 Eosinophilic Esophagitis Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstore
2.5 Eosinophilic Esophagitis Drug Sales by Application
2.5.1 Global Eosinophilic Esophagitis Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Eosinophilic Esophagitis Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Eosinophilic Esophagitis Drug Breakdown Data by Company
3.1.1 Global Eosinophilic Esophagitis Drug Annual Sales by Company (2020-2025)
3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
3.2 Global Eosinophilic Esophagitis Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Company (2020-2025)
3.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
3.3 Global Eosinophilic Esophagitis Drug Sale Price by Company
3.4 Key Manufacturers Eosinophilic Esophagitis Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eosinophilic Esophagitis Drug Product Location Distribution
3.4.2 Players Eosinophilic Esophagitis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EOSINOPHILIC ESOPHAGITIS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Eosinophilic Esophagitis Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Eosinophilic Esophagitis Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Eosinophilic Esophagitis Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Eosinophilic Esophagitis Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Eosinophilic Esophagitis Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Eosinophilic Esophagitis Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Eosinophilic Esophagitis Drug Sales Growth
4.4 APAC Eosinophilic Esophagitis Drug Sales Growth
4.5 Europe Eosinophilic Esophagitis Drug Sales Growth
4.6 Middle East & Africa Eosinophilic Esophagitis Drug Sales Growth
5 AMERICAS
5.1 Americas Eosinophilic Esophagitis Drug Sales by Country
5.1.1 Americas Eosinophilic Esophagitis Drug Sales by Country (2020-2025)
5.1.2 Americas Eosinophilic Esophagitis Drug Revenue by Country (2020-2025)
5.2 Americas Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
5.3 Americas Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eosinophilic Esophagitis Drug Sales by Region
6.1.1 APAC Eosinophilic Esophagitis Drug Sales by Region (2020-2025)
6.1.2 APAC Eosinophilic Esophagitis Drug Revenue by Region (2020-2025)
6.2 APAC Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
6.3 APAC Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Eosinophilic Esophagitis Drug by Country
7.1.1 Europe Eosinophilic Esophagitis Drug Sales by Country (2020-2025)
7.1.2 Europe Eosinophilic Esophagitis Drug Revenue by Country (2020-2025)
7.2 Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
7.3 Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Eosinophilic Esophagitis Drug by Country
8.1.1 Middle East & Africa Eosinophilic Esophagitis Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Eosinophilic Esophagitis Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eosinophilic Esophagitis Drug
10.3 Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
10.4 Industry Chain Structure of Eosinophilic Esophagitis Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eosinophilic Esophagitis Drug Distributors
11.3 Eosinophilic Esophagitis Drug Customer
12 WORLD FORECAST REVIEW FOR EOSINOPHILIC ESOPHAGITIS DRUG BY GEOGRAPHIC REGION
12.1 Global Eosinophilic Esophagitis Drug Market Size Forecast by Region
12.1.1 Global Eosinophilic Esophagitis Drug Forecast by Region (2026-2031)
12.1.2 Global Eosinophilic Esophagitis Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Eosinophilic Esophagitis Drug Forecast by Type (2026-2031)
12.7 Global Eosinophilic Esophagitis Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Adare Pharmaceuticals
13.4.1 Adare Pharmaceuticals Company Information
13.4.2 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Adare Pharmaceuticals Main Business Overview
13.4.5 Adare Pharmaceuticals Latest Developments
13.5 DBV Technologies
13.5.1 DBV Technologies Company Information
13.5.2 DBV Technologies Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DBV Technologies Main Business Overview
13.5.5 DBV Technologies Latest Developments
13.6 Dr. Falk Pharma
13.6.1 Dr. Falk Pharma Company Information
13.6.2 Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dr. Falk Pharma Main Business Overview
13.6.5 Dr. Falk Pharma Latest Developments
13.7 Quorum Innovations
13.7.1 Quorum Innovations Company Information
13.7.2 Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Quorum Innovations Main Business Overview
13.7.5 Quorum Innovations Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.8.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
13.9 Calypso
13.9.1 Calypso Company Information
13.9.2 Calypso Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Calypso Main Business Overview
13.9.5 Calypso Latest Developments
13.10 Celgene
13.10.1 Celgene Company Information
13.10.2 Celgene Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Celgene Main Business Overview
13.10.5 Celgene Latest Developments
13.11 Regeneron
13.11.1 Regeneron Company Information
13.11.2 Regeneron Eosinophilic Esophagitis Drug Product Portfolios and Specifications
13.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Regeneron Main Business Overview
13.11.5 Regeneron Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Eosinophilic Esophagitis Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Eosinophilic Esophagitis Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Budesonide
Table 4. Major Players of Fluticasone
Table 5. Major Players of Others
Table 6. Global Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 7. Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 8. Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2025) & ($ million)
Table 9. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2020-2025)
Table 10. Global Eosinophilic Esophagitis Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Eosinophilic Esophagitis Drug Sale by Application (2020-2025) & (K Units)
Table 12. Global Eosinophilic Esophagitis Drug Sale Market Share by Application (2020-2025)
Table 13. Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2025) & ($ million)
Table 14. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2020-2025)
Table 15. Global Eosinophilic Esophagitis Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 17. Global Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 18. Global Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 20. Global Eosinophilic Esophagitis Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Eosinophilic Esophagitis Drug Producing Area Distribution and Sales Area
Table 22. Players Eosinophilic Esophagitis Drug Products Offered
Table 23. Eosinophilic Esophagitis Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Eosinophilic Esophagitis Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Eosinophilic Esophagitis Drug Sales Market Share Geographic Region (2020-2025)
Table 28. Global Eosinophilic Esophagitis Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Eosinophilic Esophagitis Drug Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Eosinophilic Esophagitis Drug Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Eosinophilic Esophagitis Drug Sales Market Share by Country/Region (2020-2025)
Table 32. Global Eosinophilic Esophagitis Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Eosinophilic Esophagitis Drug Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 35. Americas Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2025)
Table 36. Americas Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 38. Americas Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 39. APAC Eosinophilic Esophagitis Drug Sales by Region (2020-2025) & (K Units)
Table 40. APAC Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2025)
Table 41. APAC Eosinophilic Esophagitis Drug Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 43. APAC Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 44. Europe Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 45. Europe Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 47. Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Eosinophilic Esophagitis Drug
Table 53. Key Market Challenges & Risks of Eosinophilic Esophagitis Drug
Table 54. Key Industry Trends of Eosinophilic Esophagitis Drug
Table 55. Eosinophilic Esophagitis Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Eosinophilic Esophagitis Drug Distributors List
Table 58. Eosinophilic Esophagitis Drug Customer List
Table 59. Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Eosinophilic Esophagitis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Eosinophilic Esophagitis Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Eosinophilic Esophagitis Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Eosinophilic Esophagitis Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Eosinophilic Esophagitis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Eosinophilic Esophagitis Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Eosinophilic Esophagitis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Eosinophilic Esophagitis Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. AstraZeneca Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. AstraZeneca Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 75. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. GSK Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 80. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Bayer Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 85. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Adare Pharmaceuticals Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 90. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Adare Pharmaceuticals Main Business
Table 92. Adare Pharmaceuticals Latest Developments
Table 93. DBV Technologies Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. DBV Technologies Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 95. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. DBV Technologies Main Business
Table 97. DBV Technologies Latest Developments
Table 98. Dr. Falk Pharma Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 100. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Dr. Falk Pharma Main Business
Table 102. Dr. Falk Pharma Latest Developments
Table 103. Quorum Innovations Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 105. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Quorum Innovations Main Business
Table 107. Quorum Innovations Latest Developments
Table 108. Takeda Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Takeda Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 110. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Takeda Main Business
Table 112. Takeda Latest Developments
Table 113. Calypso Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Calypso Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 115. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Calypso Main Business
Table 117. Calypso Latest Developments
Table 118. Celgene Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Celgene Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 120. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Celgene Main Business
Table 122. Celgene Latest Developments
Table 123. Regeneron Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Regeneron Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 125. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Regeneron Main Business
Table 127. Regeneron Latest Developments
Table 1. Eosinophilic Esophagitis Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Eosinophilic Esophagitis Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Budesonide
Table 4. Major Players of Fluticasone
Table 5. Major Players of Others
Table 6. Global Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 7. Global Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Table 8. Global Eosinophilic Esophagitis Drug Revenue by Type (2020-2025) & ($ million)
Table 9. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2020-2025)
Table 10. Global Eosinophilic Esophagitis Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Eosinophilic Esophagitis Drug Sale by Application (2020-2025) & (K Units)
Table 12. Global Eosinophilic Esophagitis Drug Sale Market Share by Application (2020-2025)
Table 13. Global Eosinophilic Esophagitis Drug Revenue by Application (2020-2025) & ($ million)
Table 14. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application (2020-2025)
Table 15. Global Eosinophilic Esophagitis Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Eosinophilic Esophagitis Drug Sales by Company (2020-2025) & (K Units)
Table 17. Global Eosinophilic Esophagitis Drug Sales Market Share by Company (2020-2025)
Table 18. Global Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 20. Global Eosinophilic Esophagitis Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Eosinophilic Esophagitis Drug Producing Area Distribution and Sales Area
Table 22. Players Eosinophilic Esophagitis Drug Products Offered
Table 23. Eosinophilic Esophagitis Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Eosinophilic Esophagitis Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Eosinophilic Esophagitis Drug Sales Market Share Geographic Region (2020-2025)
Table 28. Global Eosinophilic Esophagitis Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Eosinophilic Esophagitis Drug Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Eosinophilic Esophagitis Drug Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Eosinophilic Esophagitis Drug Sales Market Share by Country/Region (2020-2025)
Table 32. Global Eosinophilic Esophagitis Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Eosinophilic Esophagitis Drug Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 35. Americas Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2025)
Table 36. Americas Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 38. Americas Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 39. APAC Eosinophilic Esophagitis Drug Sales by Region (2020-2025) & (K Units)
Table 40. APAC Eosinophilic Esophagitis Drug Sales Market Share by Region (2020-2025)
Table 41. APAC Eosinophilic Esophagitis Drug Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 43. APAC Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 44. Europe Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 45. Europe Eosinophilic Esophagitis Drug Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 47. Europe Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Eosinophilic Esophagitis Drug Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Eosinophilic Esophagitis Drug Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Eosinophilic Esophagitis Drug Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Eosinophilic Esophagitis Drug
Table 53. Key Market Challenges & Risks of Eosinophilic Esophagitis Drug
Table 54. Key Industry Trends of Eosinophilic Esophagitis Drug
Table 55. Eosinophilic Esophagitis Drug Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Eosinophilic Esophagitis Drug Distributors List
Table 58. Eosinophilic Esophagitis Drug Customer List
Table 59. Global Eosinophilic Esophagitis Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Eosinophilic Esophagitis Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Eosinophilic Esophagitis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Eosinophilic Esophagitis Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Eosinophilic Esophagitis Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Eosinophilic Esophagitis Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Eosinophilic Esophagitis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Eosinophilic Esophagitis Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Eosinophilic Esophagitis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Eosinophilic Esophagitis Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Eosinophilic Esophagitis Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Eosinophilic Esophagitis Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. AstraZeneca Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 74. AstraZeneca Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 75. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. GSK Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 80. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Bayer Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 85. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Adare Pharmaceuticals Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 90. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Adare Pharmaceuticals Main Business
Table 92. Adare Pharmaceuticals Latest Developments
Table 93. DBV Technologies Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. DBV Technologies Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 95. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. DBV Technologies Main Business
Table 97. DBV Technologies Latest Developments
Table 98. Dr. Falk Pharma Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 100. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Dr. Falk Pharma Main Business
Table 102. Dr. Falk Pharma Latest Developments
Table 103. Quorum Innovations Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Quorum Innovations Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 105. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Quorum Innovations Main Business
Table 107. Quorum Innovations Latest Developments
Table 108. Takeda Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Takeda Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 110. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Takeda Main Business
Table 112. Takeda Latest Developments
Table 113. Calypso Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Calypso Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 115. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Calypso Main Business
Table 117. Calypso Latest Developments
Table 118. Celgene Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Celgene Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 120. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Celgene Main Business
Table 122. Celgene Latest Developments
Table 123. Regeneron Basic Information, Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Regeneron Eosinophilic Esophagitis Drug Product Portfolios and Specifications
Table 125. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Regeneron Main Business
Table 127. Regeneron Latest Developments
LIST OF FIGURES
Figure 1. Picture of Eosinophilic Esophagitis Drug
Figure 2. Eosinophilic Esophagitis Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eosinophilic Esophagitis Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Eosinophilic Esophagitis Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Eosinophilic Esophagitis Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Eosinophilic Esophagitis Drug Sales Market Share by Country/Region (2024)
Figure 10. Eosinophilic Esophagitis Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Budesonide
Figure 12. Product Picture of Fluticasone
Figure 13. Product Picture of Others
Figure 14. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2025
Figure 15. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2020-2025)
Figure 16. Eosinophilic Esophagitis Drug Consumed in Hospitals
Figure 17. Global Eosinophilic Esophagitis Drug Market: Hospitals (2020-2025) & (K Units)
Figure 18. Eosinophilic Esophagitis Drug Consumed in Clinics
Figure 19. Global Eosinophilic Esophagitis Drug Market: Clinics (2020-2025) & (K Units)
Figure 20. Eosinophilic Esophagitis Drug Consumed in Drugstore
Figure 21. Global Eosinophilic Esophagitis Drug Market: Drugstore (2020-2025) & (K Units)
Figure 22. Global Eosinophilic Esophagitis Drug Sale Market Share by Application (2024)
Figure 23. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application in 2025
Figure 24. Eosinophilic Esophagitis Drug Sales by Company in 2025 (K Units)
Figure 25. Global Eosinophilic Esophagitis Drug Sales Market Share by Company in 2025
Figure 26. Eosinophilic Esophagitis Drug Revenue by Company in 2025 ($ millions)
Figure 27. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company in 2025
Figure 28. Global Eosinophilic Esophagitis Drug Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Eosinophilic Esophagitis Drug Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Eosinophilic Esophagitis Drug Sales 2020-2025 (K Units)
Figure 31. Americas Eosinophilic Esophagitis Drug Revenue 2020-2025 ($ millions)
Figure 32. APAC Eosinophilic Esophagitis Drug Sales 2020-2025 (K Units)
Figure 33. APAC Eosinophilic Esophagitis Drug Revenue 2020-2025 ($ millions)
Figure 34. Europe Eosinophilic Esophagitis Drug Sales 2020-2025 (K Units)
Figure 35. Europe Eosinophilic Esophagitis Drug Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Eosinophilic Esophagitis Drug Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Eosinophilic Esophagitis Drug Revenue 2020-2025 ($ millions)
Figure 38. Americas Eosinophilic Esophagitis Drug Sales Market Share by Country in 2025
Figure 39. Americas Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2025)
Figure 40. Americas Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 41. Americas Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 42. United States Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Eosinophilic Esophagitis Drug Sales Market Share by Region in 2025
Figure 47. APAC Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2025)
Figure 48. APAC Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 49. APAC Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 50. China Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. India Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Eosinophilic Esophagitis Drug Sales Market Share by Country in 2025
Figure 58. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2025)
Figure 59. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 60. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 61. Germany Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. France Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 69. Egypt Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Eosinophilic Esophagitis Drug in 2025
Figure 75. Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
Figure 76. Industry Chain Structure of Eosinophilic Esophagitis Drug
Figure 77. Channels of Distribution
Figure 78. Global Eosinophilic Esophagitis Drug Sales Market Forecast by Region (2026-2031)
Figure 79. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Eosinophilic Esophagitis Drug
Figure 2. Eosinophilic Esophagitis Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eosinophilic Esophagitis Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Eosinophilic Esophagitis Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Eosinophilic Esophagitis Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Eosinophilic Esophagitis Drug Sales Market Share by Country/Region (2024)
Figure 10. Eosinophilic Esophagitis Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Budesonide
Figure 12. Product Picture of Fluticasone
Figure 13. Product Picture of Others
Figure 14. Global Eosinophilic Esophagitis Drug Sales Market Share by Type in 2025
Figure 15. Global Eosinophilic Esophagitis Drug Revenue Market Share by Type (2020-2025)
Figure 16. Eosinophilic Esophagitis Drug Consumed in Hospitals
Figure 17. Global Eosinophilic Esophagitis Drug Market: Hospitals (2020-2025) & (K Units)
Figure 18. Eosinophilic Esophagitis Drug Consumed in Clinics
Figure 19. Global Eosinophilic Esophagitis Drug Market: Clinics (2020-2025) & (K Units)
Figure 20. Eosinophilic Esophagitis Drug Consumed in Drugstore
Figure 21. Global Eosinophilic Esophagitis Drug Market: Drugstore (2020-2025) & (K Units)
Figure 22. Global Eosinophilic Esophagitis Drug Sale Market Share by Application (2024)
Figure 23. Global Eosinophilic Esophagitis Drug Revenue Market Share by Application in 2025
Figure 24. Eosinophilic Esophagitis Drug Sales by Company in 2025 (K Units)
Figure 25. Global Eosinophilic Esophagitis Drug Sales Market Share by Company in 2025
Figure 26. Eosinophilic Esophagitis Drug Revenue by Company in 2025 ($ millions)
Figure 27. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company in 2025
Figure 28. Global Eosinophilic Esophagitis Drug Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Eosinophilic Esophagitis Drug Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Eosinophilic Esophagitis Drug Sales 2020-2025 (K Units)
Figure 31. Americas Eosinophilic Esophagitis Drug Revenue 2020-2025 ($ millions)
Figure 32. APAC Eosinophilic Esophagitis Drug Sales 2020-2025 (K Units)
Figure 33. APAC Eosinophilic Esophagitis Drug Revenue 2020-2025 ($ millions)
Figure 34. Europe Eosinophilic Esophagitis Drug Sales 2020-2025 (K Units)
Figure 35. Europe Eosinophilic Esophagitis Drug Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Eosinophilic Esophagitis Drug Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Eosinophilic Esophagitis Drug Revenue 2020-2025 ($ millions)
Figure 38. Americas Eosinophilic Esophagitis Drug Sales Market Share by Country in 2025
Figure 39. Americas Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2025)
Figure 40. Americas Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 41. Americas Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 42. United States Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Eosinophilic Esophagitis Drug Sales Market Share by Region in 2025
Figure 47. APAC Eosinophilic Esophagitis Drug Revenue Market Share by Region (2020-2025)
Figure 48. APAC Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 49. APAC Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 50. China Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. India Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Eosinophilic Esophagitis Drug Sales Market Share by Country in 2025
Figure 58. Europe Eosinophilic Esophagitis Drug Revenue Market Share by Country (2020-2025)
Figure 59. Europe Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 60. Europe Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 61. Germany Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. France Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Eosinophilic Esophagitis Drug Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Eosinophilic Esophagitis Drug Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Eosinophilic Esophagitis Drug Sales Market Share by Application (2020-2025)
Figure 69. Egypt Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Eosinophilic Esophagitis Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Eosinophilic Esophagitis Drug in 2025
Figure 75. Manufacturing Process Analysis of Eosinophilic Esophagitis Drug
Figure 76. Industry Chain Structure of Eosinophilic Esophagitis Drug
Figure 77. Channels of Distribution
Figure 78. Global Eosinophilic Esophagitis Drug Sales Market Forecast by Region (2026-2031)
Figure 79. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Eosinophilic Esophagitis Drug Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Eosinophilic Esophagitis Drug Revenue Market Share Forecast by Application (2026-2031)
